Retrospect and Prospect for Lung Cancer in China: Clinical Advances of Immune Checkpoint Inhibitors

DOI: 10.1634/theoncologist.2019-IO-S1-s02

Keywords: Biogenetics, Checkpoint inhibitors, Immunotherapy, Lung cancer

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text